HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancerphenotype

Citation
Wm. Liu et al., HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancerphenotype, CANCER RES, 59(22), 1999, pp. 5695-5703
Citations number
88
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
59
Issue
22
Year of publication
1999
Pages
5695 - 5703
Database
ISI
SICI code
0008-5472(19991115)59:22<5695:HRBROM>2.0.ZU;2-T
Abstract
Base-unpairing regions (SURs) contain a specialized DNA context with an exc eptionally high unwinding propensity, and are typically identified within v arious matrix attachment regions. A BUR affinity column was used to purify a doublet of M-r 20,000 proteins from human breast carcinoma cells. These p roteins were identified as the high-mobility group (HMG) protein, HMG-I, an d its splicing variant, HMG-Y. We show that HMG-I(Y) specifically binds BUR s. Mutating BURs so as to abrogate their unwinding property greatly reduced their binding affinity to HMG-I(Y), Numerous studies have indicated that e levated HMG-I(Y) expression is correlated with more advanced cancers and wi th increased metastatic potential. We studied whether the expression of HMG -I(Y) responds to signaling through the heregulin (HRG)-erbB pathway and th e extracellular matrix. HMG-I(Y) expression was increased in MCF-7 cells af ter stable transfection with an HRG expression construct that led cells to acquire estrogen independence and metastasizing ability. A high level of HM G-I(Y) expression was detected in metastatic MDA-MB-231 cells, but the expr ession was virtually diminished, and the metastasizing ability was lost aft er cells were stably transfected with an antisense HRG cDNA construct. HMG- I(Y) was also decreased in MDA-MB-231 cells when treated with a chemical in hibitor for matrix metalloproteinase-9 that led to a reduction of invasive capability in vitro. The level of HMG-I(Y) expression, therefore, is dynami cally regulated in human breast cancer cells in response to varying types o f signaling that affect metastatic ability, including the HRG-erbB pathway and those from the extracellular matrix.